Pedersen Leif Elliott 4

What Happened

• Leif Pedersen, Chief Financial Officer of P3 Health Partners (PIII), was granted 30,000 derivative shares on May 8, 2026. The award is reported at $3.55 per share, for a total reported value of approximately $106,437. This was an award/grant (Form 4 code "A"), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-08; grant price reported: $3.55/share; total value: ~$106,437.
• Transaction type: Award/Grant of derivative securities (code A) — likely restricted stock or RSUs (the filing lists a derivative acquisition).
• Shares owned after transaction: Not specified in the public Form 4 filing.
• Filing: Reported on SEC Form 4 filed 2026-05-18 (10 days after the transaction), which appears late relative to the usual two-business-day Form 4 filing requirement.
• No footnotes in the filing indicating a 10b5-1 plan, cashless sale, or tax-withholding at grant.

Context

• This grant is most likely compensation-related (stock award/RSU) and does not necessarily reflect an immediate buy/sell signal about the insider’s view of the stock. Retail investors typically treat direct open-market purchases as stronger signals of insider conviction than compensation awards. The delayed filing may warrant attention because timely disclosure is required for transparency.